Elevated levels of HDAC8 have been reported in many cancers such as breast cancer, neuroblastoma, and acute myeloid leukemia, and these have been associated with shorter survival and more aggressive disease (Chakrabarti et al., 2016). This evidence concerns the gene HDAC8 and cancer.